[1] Singh I., Al-Wahaibi L.H., Srivastava R., Prasad O., Pathak S.K., Kumar S., Parveen S., Banerjee M., El-Emam A.A., Sinha L.,
DFT Study on the Electronic Properties, Spectroscopic Profile, and Biological Activity of 2-Amino-5-Trifluoromethyl-1, 3, 4-Thiadiazole with Anticancer Properties,
ACS omega,
5(46): 30073-30087 (2020).
[5] Queiroz A.N., Martins C.C., Santos K.L., Carvalho E.S., Owiti A.O., Oliveira K.R., Herculano A.M., da Silva A.B., Borges R.S.,
Experimental and Theoretical Study on Structure-Tautomerism Among Edaravone, Isoxazolone, and their Heterocycles Derivatives as Antioxidants,
Saudi Pharm. J.,
28(7): 819-827 (2020).
[6] Oberoi D., Dagar P., Shankar U., Vyas G., Kumar A., Sahu S., Bandyopadhyay A.,
Design, Synthesis, and Characterization of an Fe(II)-Polymer of a Redox non-Innocent, Heteroatomic, Polydentate Schiff's Base Ligand: Negative Differential Resistance and Memory Behaviour,
New J. Chem.,
42(23): 19090-19100 (2018).
[7] Namasivayam V., Vanangamudi M., Kramer V.G., Kurup S., Zhan P., Liu X., Kongsted J., Byrareddy S.N.,
The Journey of HIV-1 non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic,
J. Med. Chem., 62(10): 4851-4883 (2018).
[10] Safwat, M.A., Soliman, G.M., Sayed, D. and Attia, M.A.,
Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model,
Mol. Pharm., 15(6): 2194-2205 (2018).
[11] Sajadimajd S., Bahramsoltani R., Iranpanah A., Patra J.K., Das G., Gouda S., Rahimi R., Rezaeiamiri E., Cao H., Giampieri F., Battino M.,
Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer,
Pharmacol. Res.,
151: 104584-104620 (2020).
[21] (a) Emamian S.R., Domingo L.R., Tayyar S.F.,
Tautomerism in Pyridazin-3(2H)-One: A Theoretical Study Using Implicit/Explicit Solvation Models,
J, Mol, Graph, Model,
49: 47-54 (2014). (b) Chahkandi B., Tayyari S.F., Bakhshaei M., Chahkandi M.,
Investigation of Simple and Water Assisted Tautomerism in a Derivative of 1, 3, 4-Oxadiazole: A DFT Study,
J. Mol. Graph. Model,
44: 120-128 (2013).
[26] Wang D., Zhang X., Han X., Zhou Y., Lei Y., Gao W., Liu M., Huang X., Wu H.,
Ketone–Enol Tautomerism, Polymorphism, Mechanofluorochromism and Solid-State Acidochromism of Isoquinolinone–Arylidenehydrazine Derivatives,
J. Mater. Chem. C,
9(37): 12868-12876 (2021).
[39] Frisch M.J., Trucks G.W., Schlegel H. B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Petersson G.A., Nakatsuji H., Li X., Caricato M., Marenich A., Bloino J., Janesko B.G., Gomperts R., Mennucci B., Hratchian H.P., Ortiz J.V., Izmaylov A.F., Sonnenberg J.L., Williams-Young D., Ding F., Lipparini F., Egidi F., Goings J., Peng B., Petrone A., Henderson T., Ranasinghe D., Zakrzewski V.G., Gao J., Rega N., Zheng G., Liang W., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., Throssell K., Montgomery J. A., Jr., Peralta J. E., Ogliaro F., Bearpark M., Heyd J. J., Brothers E., Kudin K.N., Staroverov V.N., Keith T., Kobayashi R., Normand J., Raghavachari K., Rendell A., Burant J.C., Iyengar S.S., Tomasi J., Cossi M., Millam J.M., Klene M., Adamo C., Cammi R., Ochterski J. W., Martin R. L., Morokuma K., Farkas O., Foresman J. B., Fox D.J.,"
Gaussian 09, Revision A.02-SMP, Gaussian", Inc, Wallingford, CT, (2009).